Skip to main content
. 2024 Mar 21;15:1357638. doi: 10.3389/fimmu.2024.1357638

Table 2.

Epidemiology of pathogen co-infections at COVID-19 admission.

Mild cases
(n=8)
Severe cases
(n=33)
P
Single pathogen infection (%) 8 (100) 18 (54.5)
Mixed pathogen infection (%) 0 (0) 15 (45.5)
Fungal infection (%) 1 (12.5) 18 (54.5) 0.032
Candida albicans (%) 1 (12.5) 14 (42.4) 0.115
Aspergillus fumigatus (%) 0 (0) 4 (12.1)
Staphylococcus aureus (%) (G+) 2 (25) 2 (6.1) 0.105
Streptococcus pneumoniae (%) (G+) 1 (12.5) 2 (6.1) 0.530
Enterococcus faecalis (%) (G+) 0 (0) 1 (3.0)
Staphylococcus hominis (%) (G+) 0 (0) 1 (3.0)
Pseudomonas aeruginosa (G-) 1 (12.5) 4 (12.1) 0.977
Acinetobacter baumannii (G-) 0 (0) 14 (42.4)
Klebsiella pneumoniae (G-) 2 (25) 5 (15.2) 0.507
Legionella pneumophila (G-) 1 (12.5) 0 (0)
Enterobacter asburiae (G-) 0 (0) 1 (3.0)
Stenotrophomonas maltophilia (G-) 0 (0) 3 (9.1)
Escherichia coli (G-) 0 (0) 1 (3.0)
Enterobacter cloacae (G-) 0 (0) 2 (6.1)
Mycoplasma pneumoniae 0 (0) 4 (12.1)
CR-PA 0 (0) 1 (3.0)
CR-AB 0 (0) 6 (18.2)
CRE 0 (0) 1 (3.0)
No. Death 0 (0) 14 (42.4)

Results are expressed as mean ± standard deviation (SD) or percentage; P values are from a χ2 analysis. G+, Gram positive; G-, Gram negative; CRPA, carbapenem-resistant Pseudomonas aeruginosa; CRAB, carbapenem-resistant Acinetobacter baumannii; CRE, carbapenem-resistant Enterobacteriaceae.